Improved selectivity in detection of polar basic drugs by liquid chromatography–electrospray ionization mass spectrometry

M.A. Campanero , I. Bueno , M.A. Arangoa , M. Escolar , E.G. Quetglás , A. López-Ocáriz , J.R. Azanza
{"title":"Improved selectivity in detection of polar basic drugs by liquid chromatography–electrospray ionization mass spectrometry","authors":"M.A. Campanero ,&nbsp;I. Bueno ,&nbsp;M.A. Arangoa ,&nbsp;M. Escolar ,&nbsp;E.G. Quetglás ,&nbsp;A. López-Ocáriz ,&nbsp;J.R. Azanza","doi":"10.1016/S0378-4347(01)00355-3","DOIUrl":null,"url":null,"abstract":"<div><p>It is well to assume that bioanalytical chromatographic methods for the determination of polar basic drugs are developed and optimised according to a standardised procedure which involves two alternatives: (a) modifications in the sample preparation procedures, and (b) changes in the stationary phase of the chromatographic system. In this paper, a simple and rapid chromatographic procedure using a specific analytical detection method (ESI tandem mass spectrophotometric detection) in combination with a fast and efficient sample work-up procedure, protein precipitation, is presented. A demonstration of the entire chromatographic procedure is given for an HPLC method for the determination of famotidine in human plasma, a basic polar drug with poor solubility in organic solvents. In order to optimize the mass detection of famotidine, several parameters such as ionization mode, fragmentor voltage, <em>m</em>/<em>z</em> ratios of ions monitored, type of organic modifier and eluent additive, were investigated. Each analysis required 5 min. The calibration curve of famotidine in the range 1–200 ng/ml was linear with a correlation coefficient of 0.9992 (<em>n</em>=6), and a detection limit a signal-to-noise ratio of 3 was ∼0.2 ng/ml. The within- and between-day variations in the famotidine analysis were 5.2 (<em>n</em>=6) and 6.7% (<em>n</em>=18), respectively. The applicability of this method was also demonstrated for the analysis of plasma samples in a Phase-I human pharmacokinetic study.</p></div>","PeriodicalId":15463,"journal":{"name":"Journal of Chromatography B: Biomedical Sciences and Applications","volume":"763 1","pages":"Pages 21-33"},"PeriodicalIF":0.0000,"publicationDate":"2001-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0378-4347(01)00355-3","citationCount":"27","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chromatography B: Biomedical Sciences and Applications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378434701003553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 27

Abstract

It is well to assume that bioanalytical chromatographic methods for the determination of polar basic drugs are developed and optimised according to a standardised procedure which involves two alternatives: (a) modifications in the sample preparation procedures, and (b) changes in the stationary phase of the chromatographic system. In this paper, a simple and rapid chromatographic procedure using a specific analytical detection method (ESI tandem mass spectrophotometric detection) in combination with a fast and efficient sample work-up procedure, protein precipitation, is presented. A demonstration of the entire chromatographic procedure is given for an HPLC method for the determination of famotidine in human plasma, a basic polar drug with poor solubility in organic solvents. In order to optimize the mass detection of famotidine, several parameters such as ionization mode, fragmentor voltage, m/z ratios of ions monitored, type of organic modifier and eluent additive, were investigated. Each analysis required 5 min. The calibration curve of famotidine in the range 1–200 ng/ml was linear with a correlation coefficient of 0.9992 (n=6), and a detection limit a signal-to-noise ratio of 3 was ∼0.2 ng/ml. The within- and between-day variations in the famotidine analysis were 5.2 (n=6) and 6.7% (n=18), respectively. The applicability of this method was also demonstrated for the analysis of plasma samples in a Phase-I human pharmacokinetic study.

提高液相色谱-电喷雾质谱法检测极性碱性药物的选择性
可以很好地假设,用于测定极性碱性药物的生物分析色谱方法是根据标准化程序开发和优化的,该程序涉及两种选择:(a)修改样品制备程序,(b)改变色谱系统的固定相。本文介绍了一种简单、快速的色谱分析方法,该方法使用了一种特定的分析检测方法(ESI串联质谱法检测),并结合了一种快速、高效的样品处理程序——蛋白质沉淀。法莫替丁是一种碱性极性药物,在有机溶剂中溶解度较差。为了优化法莫替丁的质量检测,研究了电离方式、破碎器电压、监测离子的m/z比、有机改性剂类型和洗脱剂添加剂等参数。每次分析需要5 min。法莫替丁在1 ~ 200 ng/ml范围内的校准曲线呈线性,相关系数为0.9992 (n=6),检测限为0.2 ng/ml,信噪比为3。法莫替丁分析的日内和日间变化分别为5.2 (n=6)和6.7% (n=18)。在一期人体药代动力学研究中,也证明了该方法在血浆样品分析中的适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信